24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Polypid
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:28
Full list of Israeli high-tech funding rounds in 2024
19:24
TailorMed raises $40 million in equity and debt to help patients access critical medications
18:17
Why Israeli tech companies are moving to Miami
17:11
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
More stories
Buzz
Most popular
Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news
Polypid
6 stories about Polypid
Biotech Company Polypid Raises $15 Million
07.11.18
|
Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
CTech’s Sunday Roundup of Israeli Tech News
25.03.18
|
CTech
U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO
Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO
25.03.18
|
Dror Reich
The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week
CTech’s Thursday Israeli Tech News Roundup
15.03.18
|
CTech
Israel-based defense and homeland security manufacturer and contractor Elbit wins a $65 million contract with an unnamed Asian-Pacific country. In protest of new bonus plan, Teva sued by Israeli employees
Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO
15.03.18
|
Dror Reich
The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery
Controlled Drug Release Company Polypid Attempts Second Nasdaq IPO
11.02.18
|
Dror Reich
The Israel-based company is looking to raise up to $86.25 million to fund clinical development and trials and manufacturing activities
Please ensure Javascript is enabled for purposes of
website accessibility